This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Hsu Pei-Ling: Innovator in Immune Response Modulation
Introduction
Hsu Pei-Ling is a notable inventor based in the United States. He has made significant contributions to the field of immunology, particularly in the development of compounds that target immune cell interactions. His work focuses on controlling unwanted immune responses, which can be crucial in various medical conditions.
Latest Patents
Hsu Pei-Ling holds a patent for "Modulators Of P-Selectin Glycoprotein Ligand 1." This invention involves compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells. These compounds can be utilized to induce T cell or NK cell depletion and apoptosis. The methods derived from this invention have potential applications in managing autoimmune diseases, transplant rejection, and allergic diseases.
Career Highlights
Hsu Pei-Ling is associated with Abgenomics Cooperatief U.A., where he continues to advance his research in immune modulation. His innovative approach has positioned him as a key figure in the development of therapeutic strategies aimed at regulating immune responses.
Collaborations
Hsu Pei-Ling has collaborated with notable colleagues, including Lin Rong-Hwa and Wu Chung-Hsiun. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Hsu Pei-Ling's contributions to immunology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work has the potential to impact the treatment of various immune-related conditions significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile